ESG: from reporting obligation to opportunity for value creation
Insights from Holland Capital and Deloitte’s webinar
Amsterdam, 21st of March 2025 – On March 6, in partnership with Deloitte, we organized an engaging and inspiring ESG webinar for our portfolio companies. During the session, we explored the impact of ESG by discussing both regulations and, more importantly, opportunities for value creation. Deloitte shared valuable insights on how companies should approach ESG not just as a compliance issue, but rather as a possibility for growth and value creation.
More and more companies are facing ESG (Environmental, Social & Governance) reporting requirements. What could feel like an obligation actually offers opportunities for innovation and value creation. During the recent ESG webinar, organized by Holland Capital in collaboration with Deloitte, participating portfolio companies gained valuable insights into ESG and its impact on their organization. Below we share the key learnings from this webinar.
ESG: Why is it relevant?
ESG is not a trend, but has long been an essential aspect of how companies operate. Finding the right balance between a company’s impact on people, the environment and its (financial) performance is something the United Nations already pointed out 40 years ago. Companies should see sustainability not only as an obligation to comply with regulations, but also as an opportunity to become more efficient, transparent and future-proof.
- Environmental: How does your company affect the environment? Consider carbon emissions, energy consumption and circular economy.
- Social (social): How do you interact with employees, customers and society? Think diversity, inclusion and working conditions.
- Governance (governance): How are policy and strategy set up to conduct business ethically?
A key message from the webinar: ESG is not only relevant for large corporates, but also for SMEs. Many companies are already implementing sustainable strategies and activities, perhaps without being aware of it being labeled as sustainable. By giving this structure, entrepreneurs can leverage ESG as a competitive advantage.
Laws and regulations: What do you need to know?
An important topic discussed during the webinar was the Corporate Sustainability Reporting Directive (CSRD). A brief update on the recently proposed changes:
- Companies with more than 1,000 employees will not fall under the obligation until later.
- Large companies continue to impose ESG reporting requirements on their suppliers and supply chain partners.
- Transparency about ESG performance is becoming increasingly important to various stakeholders, such as banks, investors and potential employees.
For entrepreneurs, this means that even if their company is not (or no longer) directly in scope of the the CSRD, they could indirectly be requested to share ESG information with partners and investors. This also applies to Holland Capital: our obligations towards investors and from complying with the Sustainable Finance Disclosure Regulation (SFDR) requires our portfolio companies to provide ESG data. Those insights can be valuable and provide benefits, or identify necessary actions.
Materiality: Where do you start?
An important concept within ESG is materiality – or, in other words, which ESG topics are most relevant to your company? Materiality can be viewed from two perspectives, so-called double materiality:
- Financial impact: Which ESG topics affect profitability?
- Social impact: What impact does your company have on people and the environment?
- A structured approach helps companies not only comply with regulations, but also achieve strategic benefits.
Conclusion: ESG as a catalyst for growth?
The main message from the webinar: don’t see ESG as a burden, but as an opportunity for growth, efficiency and value creation. By understanding key material themes and responding to sustainability developments, companies can not only comply with regulations, but also gain strategic advantages.
Moreover, many companies are already engaged in sustainable initiatives and strategies – they might haven’t yet labeled them as ESG.
Investeerder Holland Venture trekt EUR 55 miljoen aan voor nieuw private equity fonds
Amsterdam, 13 december 2016 – Holland Venture is een nieuw private equity fonds gestart. Het kapitaal is bedoeld voor middelgrote Nederlandse ondernemingen die actief zijn in de sectoren Healthcare en Technology. De fundraising verliep voortvarend; binnen drie maanden...
Holland Venture raises 55 million for a new private equity fund
Amsterdam, 13th of December 2016 - Holland Venture has launched a new private equity fund. The capital is intended for small and medium-sized Dutch companies operating in the fields of Healthcare and Technology. The fundraising went expeditiously; the target amount of...
Holland Venture investeert in cloud en security specialist Avensus Nederland BV
Amsterdam, 28 november 2016 – Investeringsmaatschappij Holland Venture investeert in cloud en security specialist Avensus. De investering steunt Avensus om verdere groei binnen de financiële wereld en de zorgsector te realiseren en haar technologische expertise binnen...
Holland Venture invests in cloud & security specialist Avensus Netherlands BV
Amsterdam, November 28th, 2016 - Holland Venture invests in cloud and security specialist Avensus. The investment supports Avensus to achieve further growth in the financial and healthcare sector and to further develop its technological expertise in cloud and...
Dankzij investering in Prolira BV door Holland Venture en Health Innovations wordt snelle detectie van delirium (delier) mogelijk
27 SEPTEMBER 2016: Met een financiële injectie, kennis en een groot netwerk in de zorg helpen Holland Venture, Health Innovations en twee business angels om de Delirium Monitor van Prolira tot de nieuwe internationale gouden standaard voor detectie van delirium te...
Thanks to investment in Prolira BV, by Holland Venture and Health Innovations, early detection of delirium will be possible.
27 SEPTEMBER 2016: With a cash injection, knowledge and a large network in healthcare, Holland Venture, Health Innovations and two business angels are helping to make Prolira’s Delirium Monitor the new international standard for detection of delirium.Delirium, an...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl